Search results for “Recurrent Cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 126 patents, we discovered top 29 key players by total patent application. BioInvent International AB, Abraxis BioScience LLC, Oncimmune Ltd. are dominant in this area. They take 31.75% of the total patent filing.
BioInvent International AB
Sweden
Patent: 15
Abraxis BioScience LLC
California, United States
Patent: 13
Oncimmune Ltd.
NOTTINGHAM, United Kingdom
Patent: 12
Tesaro, Inc.
Massachusetts, United States
Patent: 11
Advaxis, Inc.
New Jersey, United States
Patent: 10
Immunomedics, Inc.
New Jersey, United States
Patent: 10
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 10
STARTUP
Blue Earth Diagnostics Ltd.
United Kingdom
Patent: 6
Introgen Therapeutics, Inc.
Texas, United States
Patent: 3
Genentech, Inc.
California, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Blue Earth Diagnostics Ltd.
United Kingdom
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 71 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing Tesaro, Inc., Merck Sharp & Dohme BV, Immunomedics, Inc. take 43.66% of patent filing during this period.
Tesaro, Inc.
Massachusetts, United States
Patent: 11
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 10
Immunomedics, Inc.
New Jersey, United States
Patent: 10
STARTUP
Blue Earth Diagnostics Ltd.
United Kingdom
Patent: 5
Hyogo College of Medicine
Hokkaido, Japan
Patent: 5
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 3
Dartmouth College
New Hampshire, United States
Patent: 3
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 3
The Methodist Hospital Research Institute
Texas, United States
Patent: 3
Health Research, Inc.
New York, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 71 patents in last 5 years, we discover 19 new entrants. Tesaro, Inc., Merck Sharp & Dohme BV, Immunomedics, Inc. are the most active new entrants in this area.
Tesaro, Inc.
Massachusetts, United States
Patent: 11
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 10
Immunomedics, Inc.
New Jersey, United States
Patent: 10
Hyogo College of Medicine
Hokkaido, Japan
Patent: 5
Health Research, Inc.
New York, United States
Patent: 3
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 3
Dartmouth College
New Hampshire, United States
Patent: 3
Kaohsiung Medical University
China
Patent: 3
The Methodist Hospital Research Institute
Texas, United States
Patent: 3
The Brigham & Women's Hospital, Inc.
Massachusetts, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 56 patents, we discovered top 7 universities and scientific research institutions by total patent application. Yale University, The University of Nottingham, Hyogo College of Medicine are dominant in this area. They take 41.07% of the total patent filing.
Yale University
Connecticut, United States
Patent: 10
The University of Nottingham
NOTTINGHAM, United Kingdom
Patent: 6
Hyogo College of Medicine
Hokkaido, Japan
Patent: 5
Dartmouth College
New Hampshire, United States
Patent: 3
Kaohsiung Medical University
China
Patent: 3
Yokohama City University
Kanagawa-ken, Japan
Patent: 2
Kyoto University
Kyoto-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: